After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

Last updated: December 11, 2025 12:25 am

0 Min Read

MedPage Today) — WASHINGTON — Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from…

Leave a Reply Cancel reply

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

Refresh Screen

Ads Blocker Detected & This Is Prohibited!!!

Refresh Screen

Top Stories

Great Lakes Wholesale International Recalls Select Battery Packs Due to Battery Ingestion; Violates Federal Statute for Child-Resistant Packaging of Button Cell and Coin Batteries

Low Vitamin D Hits Hard for Lupus Patients

After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

Stay Connected

After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

Leave a Reply Cancel reply

Related Stories

Great Lakes Wholesale International Recalls Select Battery Packs Due to Battery Ingestion; Violates Federal Statute for Child-Resistant Packaging of Button Cell and Coin Batteries

Low Vitamin D Hits Hard for Lupus Patients

Conflicting Advice on Covid Shots Likely To Ding Already Low Vaccine Rates, Experts Warn

Bridging the nutrition gap: WHO and partners strengthen care for malnourished children

USDA Announces Opening of Sterile Fly Dispersal Facility in Tampico, Mexico

Secretary Rollins Leads Largest USDA Trade Mission to Mexico, Participates in New World Screwworm Joint Reviews

Benin publishes its first health sector report and reviews a decade of progress

Ethiopia reports suspected viral haemorrhagic fever outbreak